Skip to main content
. 2019 Jun 17;2019(6):CD002253. doi: 10.1002/14651858.CD002253.pub4

Comparison 2. Vaginal misoprostol versus expectant management.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Complete miscarriage 1 614 Risk Ratio (M‐H, Fixed, 95% CI) 1.25 [1.09, 1.45]
2 Pelvic infection 1 618 Risk Ratio (M‐H, Fixed, 95% CI) 8.05 [1.87, 34.72]